Medicus Pharma Ltd. Files 6-K Report
Ticker: MDCXW · Form: 6-K · Filed: Dec 12, 2024 · CIK: 1997296
Sentiment: neutral
Topics: 6-K, disclosure, pharmaceutical
TL;DR
Medicus Pharma filed a 6-K on 12/12/24, likely with news. Check their press release.
AI Summary
Medicus Pharma Ltd. filed a Form 6-K on December 12, 2024, to report a press release dated the same day. The company, incorporated in A6 with its principal executive offices in Toronto, Canada, is involved in the Pharmaceutical Preparations industry (SIC 2834). This filing is made under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates that Medicus Pharma Ltd. is providing updated information or news to the SEC, which could be relevant for investors monitoring the company's activities and disclosures.
Risk Assessment
Risk Level: low — A 6-K filing is typically a routine disclosure of information by foreign private issuers and does not inherently signal significant risk.
Key Numbers
- 001-42408 — SEC File Number (Identifies the specific SEC filing series for Medicus Pharma Ltd.)
- 2834 — SIC Code (Indicates the company operates in the Pharmaceutical Preparations industry.)
Key Players & Entities
- Medicus Pharma Ltd. (company) — Registrant
- Raza Bokhari (person) — Signatory for Medicus Pharma Ltd.
- December 12, 2024 (date) — Filing and press release date
- Toronto, Ontario, Canada (location) — Principal executive office location
FAQ
What is the specific content of the press release filed as Exhibit 99.1?
The filing does not contain the full text of the press release, only its reference as Exhibit 99.1, dated December 12, 2024.
Does Medicus Pharma Ltd. file annual reports under Form 20-F or 40-F?
Medicus Pharma Ltd. indicated it files annual reports under Form 20-F, as noted by the checkmark next to it.
What is the primary business of Medicus Pharma Ltd. according to the filing?
The filing lists Medicus Pharma Ltd. under Standard Industrial Classification (SIC) code 2834, which corresponds to Pharmaceutical Preparations.
Who signed the Form 6-K on behalf of Medicus Pharma Ltd.?
Dr. Raza Bokhari signed the report on behalf of Medicus Pharma Ltd. on December 12, 2024.
Where are Medicus Pharma Ltd.'s principal executive offices located?
The principal executive offices of Medicus Pharma Ltd. are located at Suite 3400, 100 King St W, Toronto, Ontario, Canada, M5X 1A4.
Filing Stats: 164 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-12-12 08:16:06
Filing Documents
- form6k.htm (6-K) — 6KB
- exhibit99-1.htm (EX-99.1) — 10KB
- exhibit99-1x001.jpg (GRAPHIC) — 10KB
- 0001062993-24-020512.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicus Pharma Ltd. Date: December 12, 2024 By: /s/ Raza Bokhari Name: Dr. Raza Bokhari Title: Executive Chairman and Chief Executive Officer